Differentiating Well-Differentiated from Poorly-Differentiated HCC: The Potential and the Limitation of Gd-EOB-DTPA in the Presence of Liver Cirrhosis

URN to cite this document:: urn:nbn:de:bvb:355-epub-590826
DOI to cite this document:: 10.5283/epub.59082

Goetz, Andrea ; Verloh, Niklas

; Utpatel, Kirsten

; Fellner, Claudia

; Rennert, Janine ; Einspieler, Ingo ; Doppler, Michael ; Luerken, Lukas ; Alizadeh, Leona S. ; Uller, Wibke ; Stroszczynski, Christian

; Haimerl, Michael

License: Creative Commons Attribution 4.0
PDF - Published Version
(2MB)

Date of publication of this fulltext: 04 Sep 2024 13:11

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

This study uses magnetic resonance imaging (MRI) to investigate the potential of the hepatospecific contrast agent gadoliniumethoxybenzyl-diethylenetriaminepentaacetic acid (Gd-EOB-DTPA) in distinguishing G1- from G2/G3-differentiated hepatocellular carcinoma (HCC). Our approach involved analyzing the dynamic behavior of the contrast agent in different phases of imaging by signal intensity ...